CAI FY 2018 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$432M+24.0% YoY

Gross Profit

$214M49.4% margin

Operating Income

$149M34.4% margin

Net Income

$79M18.2% margin

EPS (Diluted)

$3.97

Cash Flow

Operating Cash Flow

$180M

Free Cash Flow

-$633M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$2.3B

Stockholders' Equity

$701M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$432M	$348M	+24.0%
Gross Profit	$214M	$169M	+26.2%
Operating Income	$149M	$106M	+40.8%
Net Income	$79M	$72M	+9.1%